Chromocell Therapeutics Corp·4

Jun 18, 8:03 PM ET

Friedberg Ezra M 4

4 · Chromocell Therapeutics Corp · Filed Jun 18, 2024

Insider Transaction Report

Form 4
Period: 2024-06-14
Transactions
  • Award

    Restricted Stock Units

    2024-06-14+64,498610,219 total
    Exercise: $1.30Exp: 2034-06-14Common Stock (64,498 underlying)
Footnotes (1)
  • [F1]On June 14, 2024, the Reporting Person was granted restricted stock units to purchase 64,498 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years.

Documents

1 file
  • 4
    ownership.xmlPrimary